Shares of uranium producers came under pressure today; the URNU.DE ETF loses more than 5%, and Uranium Energy Corp (UEC.US) shares retreat nearly 3% to $7; Canada's largest 'western' uranium miner, Cameco (CCJ.US), loses more than 3.5%.
- Uranium production operations at Block 1 of the Inkai uranium deposit in Kazakhstan, which Cameco operates jointly with Kazatomprom (KAP.UK), a joint venture, have been temporarily suspended. The state-owned Kazakh giant holds a 60% stake in the project. Cameco conveyed that it was surprised By December 30, 2024, the Inkai JV had not obtained the necessary approvals from the relevant state authorities due to delays in submitting the required documentation.
- As a result, JV Inkai decided to temporarily suspend production. The project's documentation is currently being updated and a positive outcome is expected. Data received by Cameco as recently as December 26, 2024, did not mention the risk of production suspension due to the process cited by Kazakh authorities. JV Inkai expects to submit documentation to the ministry in the coming weeks, and the situation is expected to be clarified shortly thereafter according to a January 2 statement from Kazatomprom.
- The Canadian company says it will seek further clarification on how the situation occurred, as well as the potential impact on the company's production and financial position in 2025 and 2026; also on future dividends. Kazatomprom stated that under the current circumstances it does not anticipate a significant impact on its production plans for 2025, The company has sufficient inventory levels to manage supplies throughout the year.
Cameco (H1 interval chart)
Cameco's Q4 results indicated $528 million in revenue, with just $5.45 million in net income and $0.01 in earnings per share. A valuation of around 250 price/earnings remains very challenging, especially for minign company, given potential downtime at the company's key production JV Inkai project.
Source: xStation5
📉 Microsoft Q1 2026 Earnings: Strong Numbers Mask Investor Anxiety Over AI Spending
🚀 Alphabet Soars on AI-Driven Results, Shares Rally 7% in After-Hours Trading
Meta drops 8% despite strong revenue growth 🔎
Upcoming Meta earnings: will the AI transformation be well received by the market? 🔎
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.
